Abattis Bioceuticals Corp. announced that the temporary order from the British Columbia Securities Commission (BCSC), issued on November 26, 2018, has not been extended against the company. The company announced that with the BCSC’s decision to remove the company from the Order such that Abattis can continue to focus its efforts on revenue generation and building shareholder value. The Order caused very negative sentiment towards Abattis, and with the Order lifted the company is hoping to see that sentiment and confidence towards the Company be restored. Abattis will continue to cooperate with the BCSC and Canadian Securities Exchange as much as necessary to ensure the highest level of governance and transparency as it strives towards building a first class portfolio of assets in the cannabis industry.